{"i": ["L . helveticus and B . longum", "probiotic preparation ( containing Lactobacillus helveticus and Bifidobacterium longum )", "psychological therapy", "probiotic and placebo )", "probiotic bacteria", "xylitol , maltodextrin , plum flavour and malic acid .", "probiotic", "Probiotic", "citalopram", "probiotics or placebo", "probiotics", "placebo ) Probiotic Placebo", "placebo", "caffeine , nicotine", "probiotic formula", "probiotic supplements", "active probiotic", "Placebo", "hsCRP", "probiotic formulation containing L . helveticus and B . longum", "matched placebo", "Lactobacillus helveticus", "vitamin D", "placebo - controlled", "psychotherapy", "sachet"], "o": ["serious adverse events", "vitamin D level", "Global Assessment of Functioning ( GAF )", "Gastrointestinal disturbances", "iCGI", "baseline MADRS score", "Date of birth , ethnicity , household income , occupation and highest educational qualification", "abdominal pain", "score of socio - economic status ( SES )", "mood symptoms", "mood and functioning", "BDI scores", "compliance rates", "Montgomery \u2013 A \u030a sberg Depression Rating Scale ( MADRS", "emergent adverse events", "Montgomery \u2013 A \u030a sberg Depression Rating Scale", "rates of alcohol misusers", "QIDS - SR16", "Serum IL - 1\u03b2 , IL - 6 , TNF - \u03b1 and BDNF", "level of any biomarker", "Change in appetite", "Change from BL a Vitamin D", "Irritable Bowel Syndrome Symptom Severity Scale ( IBS - SSS )", "\u00c5sberg Depression Rating Scale", "high - sensitivity C - reactive protein ( hsCRP ), IL - 1\u03b2 , IL - 6 , TNF - \u03b1 , vitamin D and BDNF .", "Nausea", "Skin rash", "Dry mouth and sleep disruption", "inflammatory markers", "body mass index ( BMI ), body fat percentage , dietary intake and physical activity", "BDI score", "Quick Inventory of Depressive Symptomatology ( QIDS - SR16", "no IBS symptoms", "psychological outcomes", "Improved Clinical Global Impressions ( iCGI ) scale", "sleep disruption", "chronicity", "cannabis users", "severity of abdominal distention , dissatisfaction with bowel habits and interference with quality of life", "Change from BL", "Depression , Anxiety and Stress Scale ( DASS", "low mood", "IBS - SSS", "clinical severity", "Probiotic Placebo Difference", "iCGI - I ratings", "biomarker levels", "suicide attempts", "Abdominal pain", "Urinary retention", "Anxiety", "attention - deficit / hyperactivity disorder ( ADHD", "prior antidepressant usage", "iCGI - S", "irritable bowel syndrome symptoms", "brain - derived neurotrophic factor ( BDNF ),", "marker of inflammation ( CRP , IL - 1\u03b2 , IL - 6 or TNF - \u03b1 )", "Plasma 25 hydroxycholecalciferol vitamin D", "Adverse events", "MADRS", "Irritable Bowel Syndrome Symptom Severity Scale", "Vitamin D levels", "mood and anxiety symptoms", "cognitive reactivity to sad mood", "HsCRP", "headaches , rash , nausea", "Constipation", "adverse events", "Loss of libido", "Beck Depression Inventory ( BDI ) scores", "emotional behaviour", "history of antidepressant usage"]}